Royal Bank of Canada (RBC) has increased its holdings in Madrigal Pharmaceuticals, Inc. by 22.5% during the first quarter.
The bank now owns 12,526 shares of the biopharmaceutical company's stock after purchasing an additional 2,303 shares during the quarter.
RBC owned 0.05% of Madrigal Pharmaceuticals worth $6.557 million as of its most recent SEC filing.
More on Forex
Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.
Market sentiment intelligence for apps, funds & agents
Location
729 55 Ave SW
Calgary AB T2V 0G4
Canada
© 2026 Guavy Inc
